HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rodger A Liddle Selected Research

Rodger A Liddle Research Topics

Disease

22Pancreatitis
01/2022 - 10/2002
10Inflammation (Inflammations)
01/2021 - 10/2002
5Chronic Pancreatitis
03/2012 - 12/2004
4Pain (Aches)
01/2016 - 01/2004
3Fibrosis (Cirrhosis)
01/2022 - 01/2010
3Necrosis
01/2022 - 07/2011
3Neurogenic Inflammation
05/2008 - 10/2002
2Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 01/2020
2Pancreatic Diseases (Pancreatic Disease)
09/2012 - 09/2005
2Edema (Dropsy)
07/2011 - 07/2006
2Body Weight (Weight, Body)
05/2008 - 03/2005
1Hypophosphatemia
01/2022
1Weight Gain
01/2022
1Insulin Resistance
01/2022
1Lewy Body Disease (Lewy Body Dementia)
01/2021
1Dementia (Dementias)
01/2021
1Parkinson Disease (Parkinson's Disease)
06/2017
1Gallstones (Gallstone)
03/2015
1Autosomal Recessive 49 Deafness
02/2015
1Autosomal Recessive 42 Deafness
02/2015
1Nonsyndromic Deafness
02/2015
1Type 2 Diabetes Mellitus (MODY)
09/2013
1Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2013
1Diabetes Mellitus
10/2011
1Atrophy
01/2010
1Feeding and Eating Disorders (Eating Disorder)
09/2007
1Bulimia Nervosa
09/2007
1Bulimia (Binge Eating)
02/2007
1Obesity
02/2007
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
02/2007
1Hyperphagia (Overeating)
02/2007
1Atrial Fibrillation
03/2006
1Adenoma (Adenomas)
03/2006

Drug/Important Bio-Agent (IBA)

7CeruletideIBA
01/2022 - 10/2002
6Peroxidase (Myeloperoxidase)IBA
03/2012 - 10/2002
5Ion Channels (Ion Channel)IBA
01/2022 - 05/2008
5Cholecystokinin (Pancreozymin)IBA
01/2022 - 03/2006
5AmylasesFDA Link
02/2014 - 10/2002
5Trypsin InhibitorsIBA
03/2012 - 12/2004
5Kazal Pancreatic Trypsin InhibitorIBA
03/2012 - 12/2004
4EnzymesIBA
01/2021 - 12/2004
4SecretagoguesIBA
05/2008 - 10/2002
3Enzyme Precursors (Zymogens)IBA
01/2022 - 01/2018
3Pharmaceutical PreparationsIBA
01/2016 - 09/2012
3Hormones (Hormone)IBA
09/2013 - 02/2007
3TrypsinogenIBA
03/2012 - 12/2004
3TrypsinIBA
03/2012 - 01/2004
3Peptide Hydrolases (Proteases)FDA Link
03/2006 - 01/2004
2Adenosine Triphosphate (ATP)IBA
01/2022 - 01/2021
2Phosphates (Orthophosphate)IBA
01/2022 - 01/2021
2Ethanol (Ethyl Alcohol)IBA
01/2021 - 02/2014
2Proteins (Proteins, Gene)FDA Link
01/2021 - 09/2013
2CalciumIBA
01/2021 - 01/2020
2SynucleinsIBA
01/2021 - 06/2017
2Leukotriene B4IBA
01/2015 - 07/2011
2resiniferatoxinIBA
01/2015 - 05/2008
2MK-886IBA
01/2015 - 07/2011
2NeuropeptidesIBA
09/2013 - 08/2007
2Insulin (Novolin)FDA Link
02/2007 - 09/2005
2Substance PIBA
07/2006 - 01/2004
1Extracellular Matrix ProteinsIBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1Protein Isoforms (Isoforms)IBA
01/2016
1Irritants (Vesicants)IBA
01/2016
1MARVEL Domain Containing 2 ProteinIBA
02/2015
1Taurocholic Acid (Sodium Taurocholate)IBA
01/2015
1N-acetyltalosaminuronic acid (NAT)IBA
01/2015
13- (4- t- butylphenyl)- N- (2,3- dihydrobenzo(b)(1,4)dioxin- 6- yl)acrylamideIBA
02/2014
1palmitoleic acidIBA
02/2014
1CytokinesIBA
09/2013
1Amino AcidsFDA Link
09/2013
1Fatty Acids (Saturated Fatty Acids)IBA
03/2013
1LipidsIBA
03/2013
14-O-carboxymethylascochlorinIBA
03/2012
1Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA
10/2011
1capsazepineIBA
07/2011
1AcidsIBA
11/2010
1Messenger RNA (mRNA)IBA
01/2010
1Transforming Growth Factor beta (TGF-beta)IBA
01/2010
1CollagenIBA
01/2010
1Collagen Type I (Type I Collagen)IBA
01/2010
1Fibronectins (Fibronectin)IBA
01/2010
1NeurotoxinsIBA
05/2008
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
05/2008
1Dietary Fats (Dietary Fat)IBA
02/2007
1Bacterial ToxinsIBA
02/2007
1TRPV Cation ChannelsIBA
07/2006
1Peptides (Polypeptides)IBA
07/2006
1Warfarin (Coumadin)FDA LinkGeneric
03/2006
1ximelagatran (Exanta)IBA
03/2006
1Sulfasalazine (Azulfidine)FDA LinkGeneric
03/2005
1Drinking WaterIBA
03/2005
1Clostridium difficile tcdA proteinIBA
03/2005
14-aminophenylacetic acidIBA
03/2005

Therapy/Procedure

4Intraperitoneal Injections
01/2015 - 03/2005
3Ligation
01/2022 - 10/2002
1Pancreatectomy
01/2021
1Therapeutics
10/2011
1Ganglionectomy
07/2006
1Oral Administration
03/2006